Songyan Zheng
About Songyan Zheng
Songyan Zheng is a Senior Principal Scientist at Bristol-Myers Squibb with over 15 years of experience in drug product manufacturing and expertise in oncology, immunology, and infectious diseases.
Title
Songyan Zheng currently holds the title of Senior Principal Scientist at Bristol-Myers Squibb in the United States.
Education and Expertise
Songyan Zheng earned a Ph.D. in Applied Chemistry and Bioengineering from The University of Tokyo, where she studied from 1992 to 1998. Additionally, Zheng pursued further studies at the University of Pennsylvania, specializing in protein structures and their functional relationships. Fluent in English, Chinese, and Japanese, Zheng brings a comprehensive background in drug product manufacturing, with over 15 years of experience across all stages of clinical development.
Professional Background
Songyan Zheng has a diverse professional background, including a seven-year tenure as a research scientist at the University of Pennsylvania and five years as a Research Investigator I/II at Medarex in Central NJ. From 2015 to 2018, Zheng was Chair of Parenteral Science and Technology, Technical Series at Bristol-Myers Squibb. Zheng also served on the Scientific Advisory Board at Bristol-Myers Squibb from 2017 to 2018.
Current Roles
Currently, Songyan Zheng serves as a Senior Principal Scientist at Bristol-Myers Squibb and is a member of the Ambassadors Coordination Committee (ACC) at the American Association of Pharmaceutical Scientists (AAPS) in the United States.
Industry Contributions
Songyan Zheng has led the development of fixed dose ratio combinations of monoclonal antibodies (mAbs) at Bristol-Myers Squibb. Zheng has developed bio-analytical methods for drug product characterization and regulatory submission support. Additionally, Zheng has managed external project collaborations and outsourcing related to drug product development and worked on subcutaneous drug product development and delivery techniques for both subcutaneous and intravenous administrations. With expertise spanning oncology, immunology, and infectious diseases, Zheng has authored 25 peer-reviewed scientific papers and delivered 23 presentations at national and international conferences.